These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36628052)

  • 1. Management of Wrong Blood Transfusion to an RhD Negative Woman in Labor.
    Titze TL; Hamnvik LHD; Hauglum IM; Carlsen AET; Tjeldhorn L; Nguyen NT; Akkök ÇA
    Int J Womens Health; 2023; 15():1-6. PubMed ID: 36628052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-D Alloimmunization After RhD Positive Red Cell Transfusion to Selected RhD Negative Patients.
    Pandey P; Setya D; Singh MK
    Indian J Hematol Blood Transfus; 2022 Jul; 38(3):577-584. PubMed ID: 35747571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological principle of development of red blood cell alloimmunization in pregnancy, hemolytic disease of the fetus and prevention of RhD alloimmunization in RhD negative women.
    Roubalová L; Lubušký M
    Ceska Gynekol; 2020; 85(6):408-416. PubMed ID: 33711901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma.
    Yazer MH; Panko G; Holcomb JB; Kaplan A; Leeper C; Seheult JN; Triulzi DJ; Spinella PC
    Hematology; 2023 Dec; 28(1):2161215. PubMed ID: 36607150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
    Yazer MH; Spinella PC; Sperry J; Triulzi DJ; Leeper C
    Transfusion; 2023 May; 63 Suppl 3():S54-S59. PubMed ID: 37067374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland.
    Susila S; Ilmakunnas M; Lauronen J; Vuorinen P; Ångerman S; Sainio S
    Transfusion; 2024 May; 64 Suppl 2():S119-S125. PubMed ID: 38240146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
    Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
    Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
    Seheult JN; Callum J; Delaney M; Drake R; Dunbar NM; Harm SK; Hess JR; Jackson BP; Javanbakht A; Moore SA; Murphy MF; Raval JS; Staves J; Tuott EE; Wendel S; Ziman A; Yazer MH;
    Transfusion; 2022 Aug; 62 Suppl 1():S185-S192. PubMed ID: 35748692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid ABO and RhD test demonstrates high fidelity to blood bank testing for RhD typing.
    Younes R; Spinella PC; Shea SM; Bailey-Kroll L; Neal MD; Leeper C; Yazer MH
    Transfusion; 2023 May; 63 Suppl 3():S208-S212. PubMed ID: 37067381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Guideline for prevention of RhD alloimmunizationin RhD negative women].
    Lubušký M; Procházka M; Simetka O; Holusková I
    Ceska Gynekol; 2013 Apr; 78(2):132-3. PubMed ID: 23710977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A RhD negative patient failed to produce detectable anti-D after transfusion of 35 units of RhD positive red blood cells].
    Lee WM; Kim JH; Ha JS; Ryoo NH; Jeon DS; Kim JR; Cho D
    Korean J Lab Med; 2007 Oct; 27(5):369-72. PubMed ID: 18094603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two Cases of Anti-D Alloimmunization in D-Negative Thai Patients as a Result of the Asian-Type DEL on Transfused Red Cells.
    Suksard K; Luangtrakool K; Rungroung T; Chamsai S; Saetam P; Kittisares K; Permpikul P; Kittivorapart J
    Transfus Med Hemother; 2024 Apr; 51(2):122-125. PubMed ID: 38584693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red Cell Alloimmunization to Rhesus Antigen Among Pregnant Women Attending a Tertiary Care Hospital in Oman.
    Al-Dughaishi T; Al Harrasi Y; Al-Duhli M; Al-Rubkhi I; Al-Riyami N; Al Riyami A; Pathare AV; Gowri V
    Oman Med J; 2016 Jan; 31(1):77-80. PubMed ID: 26813962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Standardization of the quantitative flow cytometric test with anti-D antibodies for fetomaternal hemorrhage in RhD negative women].
    Spychalska J; Uhrynowska M; Pyl H; Klimczak-Jajor E; Kopeć I; Peciakowska M; Gutowska R; Gawlak M; Słomska S; Dąbkowska S; Szczecina R; Dębska M; Brojer E
    Ginekol Pol; 2015 Jul; 86(7):486-93. PubMed ID: 26376524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibility to identify fetomaternal haemorrhage].
    Studnicková M; L'ubuský M; Ordeltová M; Procházka M
    Ceska Gynekol; 2010 Oct; 75(5):443-6. PubMed ID: 21374922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory Monitoring of Mother, Fetus, and Newborn in Hemolytic Disease of Fetus and Newborn.
    Dziegiel MH; Krog GR; Hansen AT; Olsen M; Lausen B; Nørgaard LN; Bergholt T; Rieneck K; Clausen FB
    Transfus Med Hemother; 2021 Oct; 48(5):306-315. PubMed ID: 34803574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe anti-D haemolytic disease of fetal and newborn in rhesus D negative primigravida.
    Hassan MZ; Iberahim S; Abdul Rahman WSW; Zulkafli Z; Bahar R; Ramli M; Mohd Noor NH; Mustaffa R
    Malays J Pathol; 2019 Apr; 41(1):55-58. PubMed ID: 31025639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of rhesus D-negative blood type and the challenges of rhesus D immunoprophylaxis among obstetric population in Ethiopia: a systematic review and meta-analysis.
    Ayenew AA
    Matern Health Neonatol Perinatol; 2021 Feb; 7(1):8. PubMed ID: 33531050
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.